These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20671753)

  • 21. The clinical and economic benefits of GnRH agonist in treating endometriosis.
    Glasser M
    Am J Manag Care; 1999 May; 5(5 Suppl):S316-26. PubMed ID: 10537664
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical experience treating endometriosis with nafarelin.
    Claesson B; Bergquist C
    J Reprod Med; 1989 Dec; 34(12 Suppl):1025-8. PubMed ID: 2533617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
    Engel JB; Schally AV
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elagolix: First Global Approval.
    Lamb YN
    Drugs; 2018 Sep; 78(14):1501-1508. PubMed ID: 30194661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of early drug development for endometriosis.
    Leone Roberti Maggiore U; Ferrero S
    Expert Opin Investig Drugs; 2016; 25(2):227-47. PubMed ID: 26619754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GnRH analogs: options for endometriosis-associated pain treatment.
    Batzer FR
    J Minim Invasive Gynecol; 2006; 13(6):539-45. PubMed ID: 17097577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GnRH agonists for endometriosis. These newly approved agents are effective but expensive.
    Fraser IS
    Med J Aust; 1995 Jan; 162(2):61-2. PubMed ID: 7838026
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis.
    Wong KH; Simon JA
    Am J Obstet Gynecol; 2004 Jan; 190(1):44-9. PubMed ID: 14749633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis.
    Fedele L; Bianchi S; Montefusco S; Frontino G; Carmignani L
    Fertil Steril; 2008 Jul; 90(1):183-4. PubMed ID: 18177868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
    Fang F; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):506-8. PubMed ID: 11360603
    [No Abstract]   [Full Text] [Related]  

  • 32. Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor.
    Chen C; Wu D; Guo Z; Xie Q; Reinhart GJ; Madan A; Wen J; Chen T; Huang CQ; Chen M; Chen Y; Tucci FC; Rowbottom M; Pontillo J; Zhu YF; Wade W; Saunders J; Bozigian H; Struthers RS
    J Med Chem; 2008 Dec; 51(23):7478-85. PubMed ID: 19006286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endometriosis and diferelin].
    Akush Ginekol (Sofiia); 2003; 42 Suppl 1():27-8. PubMed ID: 12899124
    [No Abstract]   [Full Text] [Related]  

  • 35. Progestins and medical treatment of endometriosis - physiology, history and society.
    Belaisch J
    Gynecol Endocrinol; 2009 Nov; 25(11):751-6. PubMed ID: 19903054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pains of endometriosis.
    Berkley KJ; Rapkin AJ; Papka RE
    Science; 2005 Jun; 308(5728):1587-9. PubMed ID: 15947176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the mechanisms of action of LHRH analogs and steroids in the treatment of endometriosis.
    Bouchard P; Garcia E
    Contrib Gynecol Obstet; 1987; 16():260-5. PubMed ID: 3121250
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of nafarelin in the management of endometriosis.
    Henzl MR
    J Reprod Med; 1989 Dec; 34(12 Suppl):1021-4. PubMed ID: 2533616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
    Kang JL; Wang XX; Nie ML; Huang XH
    Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of endometriosis with diphereline].
    Novachkov V; Damianov L
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():30-1. PubMed ID: 15323314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.